ZEB1 promotes the immune escape of ovarian cancer through the MCSF-CCL18 axis.

Cancer Cell Int · 2025 · PMC11909986 · PMID 40089803

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

Effects of ZEB1 on the tumorigenesis of ovarian cancer cells in vivo Results of the present study indicated that the growth rate in the Sh-ZEB1 group was markedly lower than that of the NC group, and this difference was apparent from Week 3 (Fig. 4 D).

also in 290 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.